Results 191 to 200 of about 24,289,840 (307)

Retraction: Country-level institutional quality and financial system efficiency: An international evidence. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

What is the role of institutional quality in health outcomes? A panel data analysis on 158 countries from 2001-2020. [PDF]

Heliyon, 2023
Hadipour A, Delavari S, Bayati M.
europepmc   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach, Sandra Donkervoort, Carola Hedberg‐Oldfors, Giovanni Baranello, Dimah Saade, Precilla D'Souza, Ruchee Patel, Eva Michael, A. Reghan Foley, Diana Bharucha‐Goebel, S. Jin Haugland, Meghan McAnally, Omer Abdul Hamid, Katherine Chao, Ellen F. Macnamara, Alan H. Beggs, Anna Sarkozy, Juliane Mueller, Steven A. Moore, Richard S. Finkel, Cynthia J. Tifft, Francesco Muntoni, Anders Oldfors, Carsten G. Bönnemann   +23 more
wiley   +1 more source

Shaping Somalia's environmental sustainability: the role of institutional quality, renewable energy, economic growth, and financial globalization on load capacity factor. [PDF]

Sci Rep
Daror HO, Warsame AA, Ahmed Z.
europepmc   +1 more source

The importance of institutional quality: Reviewing the relevance of Indonesia's Omnibus Law on national competitiveness. [PDF]

Humanit Soc Sci Commun, 2022
Jazuli MR, Idris MM, Yaguma P.
europepmc   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Institutional quality, aid flows, and malaria burden: a geospatial analysis of sub-Saharan Africa. [PDF]

Malar J
Namubiru C.
europepmc   +1 more source

How institutional quality, and energy production sources, affect the environmental sustainability of bri countries: A comparison of different income groups. [PDF]

PLoS One, 2023
Sheng W, Meng F, Akbar MW.
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Do environmental degradation and geopolitical risk hinder life expectancy? The role of institutional quality and technological innovation. [PDF]

Front Public Health
Zhan Y, Yin H, Zhang X.
europepmc   +1 more source